Key result
Real-time three-dimensional echocardiography provided accurate assessment of right ventricular systolic function, with RVEF strongly correlating with cardiac magnetic resonance measurements (r = 0.833, P < 0.001).
Why the study?
Does real-time three-dimensional echocardiography accurately assess right ventricular systolic function compared to cardiac magnetic resonance and 2-dimensional echocardiography in patients with pulmonary hypertension?
Cross-Sectional (n=23)
No
Does real-time three-dimensional echocardiography accurately assess right ventricular systolic function compared to cardiac magnetic resonance and 2-dimensional echocardiography in patients with pulmonary hypertension?
Effect estimate: r = 0.833
p-value: p=<0.001
Real-time three-dimensional echocardiography is a viable and accurate noninvasive method for assessing right ventricular systolic function in patients with pulmonary hypertension, showing good agreement with cardiac magnetic resonance.
Supports 3D echocardiography for RV assessment in pulmonary hypertension; leaves open prospective outcome validation versus CMR.
BACKGROUND: The convenience and availability of real-time three-dimensional echocardiography (RT3DE) makes it an attractive candidate for assessing right ventricle function. However, the viability of RT3DE is not conclusive. AIM OF STUDY: This study aims to evaluate RT3DE relative to cardiac magnetic resonance and 2-dimensional echocardiography (2DE) for measuring right ventricular systolic function in patients with pulmonary hypertension. METHODS: Patients with pulmonary hypertension (n = 23) underwent cardiac magnetic resonance, 2DE, and RT3DE. Specifically, 2DE was used to measure the right ventricular index of myocardial performance (RIMP), fractional area change, tricuspid annular plane systolic excursion (TAPSE), and tissue Doppler-derived tricuspid annular systolic velocity (S'). Cardiac magnetic resonance and RT3DE were used to measure right ventricular end-diastolic volume (RVEDV) and end-systolic volume (RVESV). The right ventricular ejection fraction (RVEF) was calculated. RESULTS: Regarding the measurements taken by 2DE, RVEF positively correlated with fractional area change (r = 0.595, P = 0.003) and S'(r = 0.489, P = 0.018), and negatively correlated with RIMP (r = -0.745, P = 0.000). There was no association between RVEF and TAPSE (r = -0.029, P = 0.896). There existed a close correlation between the values of RVEDV, RVESV, and RVEF as measured by RT3DE and CMR respectively (P<0.001); Bland-Altmanan analyses showed good agreement between them. CONCLUSION: RT3DE was a viable method for noninvasive, accurate assessment of right ventricular systolic function in patients with pulmonary hypertension.
No takes yet. Share an insight, caveat, or question.
Li et al. (2015) conducted a cross-sectional in Pulmonary hypertension (n=23). Real-Time Three-Dimensional Echocardiography (RT3DE) vs. Cardiac magnetic resonance (CMR) and 2-dimensional echocardiography (2DE) was evaluated on Correlation of right ventricular ejection fraction (RVEF) between RT3DE and CMR (r = 0.833, p=<0.001). Real-time three-dimensional echocardiography provided accurate assessment of right ventricular systolic function, with RVEF strongly correlating with cardiac magnetic resonance measurements (r = 0.833, P < 0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: